Vertex to acquire ViaCyte for $320 million PEG评论 07/12/2022 On July 11, Vertex announced that it had reached an agreement with ViaCyte to acquire the latter for $320 million, with the aim of accelerating Read More »
The Crucial Role of Payloads in Drug Research and Development: Spotlight on Exatecan and Irinotecan 04/10/2023